课题基金 / 基金详情

项目摘要

项目成果

JOHN A THOMPSON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A well-developed experimental model for two-stage carcinogenesis in mouse lung involves a single dose of an initiator followed by multiple doses of the phenolic antioxidant BHT. The dramatic enhancement of tumorigenesis in this system is due to the formation of quinone methides by pulmonary cytochromes P450. These metabolites are electrophilic and bind to cellular proteins producing a number of effects that eventually lead to enhanced tumor formation. Our goals for the next phase of this project are to identify the important targets of BHT-derived quinone methides and determine the roles such adducts in promotion. The resulting data will address our working hypothesis that electrophilic promoters function through the formation of covalent adducts with proteins involved in cell signaling. We will utilize a number of effective tools to detect and identify important adducts, including structural analogs of BHT with differing promotion potencies, Clara and type 2 cells from the lungs of promotion-sensitive (B+) and promotion-resistant (B-) mouse strains, non-tumorigenic cell lines derived from mouse lung epithelia and the tumorigenic siblings, polyclonal antibodies that recognize the phenol group, and a variety of mass spectrometric techniques. The results from this work will enable improved insights into the mechanisms of tumor promotion by electrophilic metabolites. The specific aims are as follows. Aim 1: Identify selected protein targets of quinone methides in lung cells from promotion-sensitive (B+) and promotion-resistant (B-) strains of mice and in tumorigenic and non-tumorigenic epithelial cell lines, and assess their roles in promoting the selective clonal expansion of initiated cells. Protein adducts formed in differing amounts in the comparison cell groups will be flagged for identification. Aim 2: Investigate biochemical effects of relevance to promotion resulting from metabolically-generated quinone methides produced in epithelial cell lines and cells isolated from mouse lung. Oxidative stress and effects on antioxidant enzymes will be determined in cell lines expressing cytochrome P450 and in Clara and type 2 cells isolated from B+/B- mice. The effects of quinone methides on gap junctional intercellular communication and apoptosis will be determined; protein expression and protein phosphorylation will be examined in the cell lines and isolated cells using isotope-coded affinity tags and mass spectrometry.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
Responses of tumorigenic and non-tumorigenic mouse lung epithelial cell lines to electrophilic metabolites of the tumor promoter butylated hydroxytoluene.
致瘤性和非致瘤性小鼠肺上皮细胞系对肿瘤启动子丁基化羟基甲苯的亲电子代谢物的反应。
DOI: 10.1016/s0009-2797(02)00161-8
发表时间: 2003
期刊: Chemico-biological interactions
影响因子: 5.1
作者: [Sun,Yude, Dwyer-Nield,LoriD, Malkinson,AlvinM, Zhang,YanLing, Thompson,JohnA]
通讯作者: Thompson,JohnA
Studies using structural analogs and inbred strain differences to support a role for quinone methide metabolites of butylated hydroxytoluene (BHT) in mouse lung tumor promotion.
使用结构类似物和近交株差异的研究支持丁基羟基甲苯 (BHT) 的醌甲基化物代谢物在小鼠肺癌促进中的作用。
DOI: 10.1016/s0300-483x(00)00449-2
发表时间: 2001
期刊: Toxicology
影响因子: 4.5
作者: [Thompson,JA, Carlson,TJ, Sun,Y, Dwyer-Nield,LD, Malkinson,AM]
通讯作者: Malkinson,AM
Fate of free radicals generated during one-electron reductions of 4-alkyl-1,4-peroxyquinols by cytochrome P-450.
细胞色素 P-450 对 4-烷基-1,4-过氧化醌进行单电子还原时产生的自由基的命运。
DOI: 10.1021/tx00006a010
发表时间: 1988
期刊: Chemical research in toxicology
影响因子: 4.1
作者: [Yumibe,NP, Thompson,JA]
通讯作者: Thompson,JA
DOI: 10.1021/tx00030a014
发表时间: 1992-11
期刊: Chemical research in toxicology
影响因子: 4.1
作者: [J. Bolton;L. Valerio;John A. Thompson]
通讯作者: J. Bolton;L. Valerio;John A. Thompson
12
    A PHASE I EVALUATION OF THE SAFETY AND PK OF PRO-1 IN STAGE IV MELANOMA PATIENTS
    • 批准号:
      7379363
    • 项目类别:
    • 资助金额:
      $0.33万
    • 财政年份:
      2006
    • 负责人:
      JOHN A THOMPSON
    • 依托单位:
    A PHASE I STUDY TO EVALUATE THE SAFETY AND PK OF PRO-1 IN STAGE IV PATIENTS
    • 批准号:
      7198874
    • 项目类别:
    • 资助金额:
      $0.57万
    • 财政年份:
      2005
    • 负责人:
      JOHN A THOMPSON
    • 依托单位:
    Allo Stem Cell Transplant as Immunotherapy for Melanoma
    Allo Stem Cell Transplant as Immunotherapy for Melanoma
    海外基金